{"id":"https://openalex.org/W121491609","doi":null,"title":"Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.","display_name":"Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W121491609","mag":"121491609","pmid":"https://pubmed.ncbi.nlm.nih.gov/16336034"},"language":"en","primary_location":{"id":"pmid:16336034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16336034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002538047","display_name":"Pierre Blier","orcid":"https://orcid.org/0000-0002-9196-0706","observed_orcids":["https://orcid.org/0000-0002-9196-0706","https://orcid.org/0000-0003-1881-2421"]},"institutions":[{"id":"https://openalex.org/I153718931","display_name":"University of Ottawa","ror":"https://ror.org/03c4mmv16","country_code":"CA","type":"education","lineage":["https://openalex.org/I153718931"]},{"id":"https://openalex.org/I4405262572","display_name":"Institute of Mental Health Research","ror":"https://ror.org/042cm9p56","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I153718931","https://openalex.org/I4405262572"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Pierre Blier","raw_affiliation_strings":["Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada. pblier@rohcg.on.ca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada. pblier@rohcg.on.ca","institution_ids":["https://openalex.org/I153718931","https://openalex.org/I4405262572"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021893691","display_name":"Steve T Szabo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve T Szabo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.681,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.9661415,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"66 Suppl 8","issue":null,"first_page":"30","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9919999837875366},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.7670000195503235},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9599999785423279},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8569999933242798},{"id":"https://openalex.org/keywords/5-ht2a-receptor-antagonism","display_name":"5-HT2A receptor antagonism","score":0.8889999985694885},{"id":"https://openalex.org/keywords/locus-coeruleus","display_name":"locus coeruleus","score":0.7720000147819519},{"id":"https://openalex.org/keywords/noradrenaline-release","display_name":"noradrenaline release","score":0.8859999775886536},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.8840000033378601},{"id":"https://openalex.org/keywords/ssri-augmentation","display_name":"SSRI augmentation","score":0.7319999933242798},{"id":"https://openalex.org/keywords/dopamine-receptors","display_name":"dopamine receptors","score":0.847000002861023},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/serotonin-terminals","display_name":"serotonin terminals","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.7034668922424316},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.5912050008773804},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5764292478561401},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.4509071111679077},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.4498976767063141},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.44635117053985596},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4290352463722229},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.42897939682006836},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.40788814425468445},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4074784517288208},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3907850384712219},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37836870551109314},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37693148851394653},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3210127353668213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30911433696746826},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.28202006220817566},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.25432121753692627},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.22327420115470886},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.09848761558532715}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008125","descriptor_name":"Locus Coeruleus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008125","descriptor_name":"Locus Coeruleus","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011903","descriptor_name":"Raphe Nuclei","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011903","descriptor_name":"Raphe Nuclei","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011941","descriptor_name":"Receptors, Adrenergic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011941","descriptor_name":"Receptors, Adrenergic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016548","descriptor_name":"Prosencephalon","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016548","descriptor_name":"Prosencephalon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16336034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16336034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:121491609","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16336034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W1930454256","https://openalex.org/W1933570072","https://openalex.org/W1964731035","https://openalex.org/W1966161934","https://openalex.org/W1967603237","https://openalex.org/W1969855549","https://openalex.org/W1970894938","https://openalex.org/W1972676417","https://openalex.org/W1978526726","https://openalex.org/W1979700184","https://openalex.org/W1980579193","https://openalex.org/W1982588519","https://openalex.org/W1983160636","https://openalex.org/W1986637546","https://openalex.org/W1987671737","https://openalex.org/W1988849721","https://openalex.org/W1990423689","https://openalex.org/W1993358235","https://openalex.org/W1993930074","https://openalex.org/W1994550766","https://openalex.org/W2000639093","https://openalex.org/W2002176890","https://openalex.org/W2002640007","https://openalex.org/W2005066505","https://openalex.org/W2005457043","https://openalex.org/W2010928240","https://openalex.org/W2015310163","https://openalex.org/W2015997342","https://openalex.org/W2017162619","https://openalex.org/W2018487237","https://openalex.org/W2021560190","https://openalex.org/W2023437958","https://openalex.org/W2027934187","https://openalex.org/W2030042250","https://openalex.org/W2032980276","https://openalex.org/W2035266273","https://openalex.org/W2043551385","https://openalex.org/W2044222412","https://openalex.org/W2047873128","https://openalex.org/W2051068515","https://openalex.org/W2052774577","https://openalex.org/W2058180685","https://openalex.org/W2060071097","https://openalex.org/W2063920907","https://openalex.org/W2064437174","https://openalex.org/W2064704756","https://openalex.org/W2064905891","https://openalex.org/W2065033597","https://openalex.org/W2069153421","https://openalex.org/W2078064581","https://openalex.org/W2085776054","https://openalex.org/W2088286873","https://openalex.org/W2114693958","https://openalex.org/W2130196047","https://openalex.org/W2133565799","https://openalex.org/W2134714040","https://openalex.org/W2137286718","https://openalex.org/W2138538218","https://openalex.org/W2139279059","https://openalex.org/W2141900936","https://openalex.org/W2159990726","https://openalex.org/W2167193786","https://openalex.org/W2272750893","https://openalex.org/W2280261174","https://openalex.org/W2407073952","https://openalex.org/W2417274625","https://openalex.org/W2471657838"],"related_works":["https://openalex.org/W2061850641","https://openalex.org/W1993769397","https://openalex.org/W2786328933","https://openalex.org/W183232061","https://openalex.org/W3095162976","https://openalex.org/W1986484493","https://openalex.org/W1982937133","https://openalex.org/W2003058676","https://openalex.org/W2397893771","https://openalex.org/W2087877032"],"abstract_inverted_index":{"The":[0,73],"serotonin":[1,26,32,59,69,127],"(5-HT)":[2],"and":[3,16,70,124],"norepinephrine":[4,47,71],"neurons":[5],"have":[6],"reciprocal":[7],"interactions":[8],"at":[9],"the":[10,37,42,56,63,83],"level":[11],"of":[12,22,58,87],"their":[13],"cell":[14],"bodies":[15],"nerve":[17],"terminals.":[18,128],"As":[19],"an":[20,104],"illustration":[21],"such":[23],"connections,":[24],"selective":[25],"reuptake":[27,60],"inhibitors":[28],"(SSRIs)":[29],"gradually":[30],"enhance":[31],"transmission":[33],"not":[34],"only":[35],"in":[36,41,55,91,108,115],"forebrain":[38],"but":[39],"also":[40],"locus":[43],"ceruleus,":[44],"thereby":[45],"decreasing":[46],"neuronal":[48],"firing.":[49],"In":[50,94],"contrast,":[51],"blocking":[52],"5-HT2A":[53],"receptors":[54,123],"presence":[57],"inhibition":[61],"using":[62],"experimental":[64],"compound":[65],"YM992":[66],"enhances":[67],"both":[68],"release.":[72],"latter":[74],"pharmacologic":[75],"effect":[76,86,112],"may":[77,113],"be":[78,103],"a":[79],"main":[80],"contributor":[81],"to":[82,102],"robust":[84],"antidepressant":[85],"adding":[88],"atypical":[89],"antipsychotics":[90],"SSRI-resistant":[92,109],"patients.":[93,110],"obsessive-compulsive":[95],"disorder,":[96],"risperidone":[97],"has":[98],"consistently":[99],"been":[100],"reported":[101],"effective":[105],"augmentation":[106],"strategy":[107],"This":[111],"result":[114],"part":[116],"from":[117],"its":[118],"antagonistic":[119],"actions":[120],"on":[121,126],"dopaminergic":[122],"alpha2-adrenoceptors":[125]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}